Joseph L. Kuti

Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

Chonghua Li, Xiaoli Du, Joseph L. Kuti et al. · Antimicrobial Agents and Chemotherapy · 2007 · 292 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem

Joseph L. Kuti, Prachi K. Dandekar, Charles H. Nightingale et al. · The Journal of Clinical Pharmacology · 2003 · 198 citations

Medicine, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients

Chonghua Li, Joseph L. Kuti, Charles H. Nightingale et al. · The Journal of Clinical Pharmacology · 2006 · 171 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection

William K. Lau, David F. Mercer, Kamal M.F. Itani et al. · Antimicrobial Agents and Chemotherapy · 2006 · 146 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Impact of Extended-Spectrum <i>β</i> -Lactamase–Producing <i>Escherichia coli</i> and <i>Klebsiella</i> Species on Clinical Outcomes and Hospital Costs: A Matched Cohort Study

Su Young Lee, Srividya Kotapati, Joseph L. Kuti et al. · Infection Control and Hospital Epidemiology · 2006 · 142 citations

Life Sciences, Infectious Diseases, Pharmacoeconomics +15